BDBM430012 2-((4-(N-(3-bromo-4- fluorophenyl)-N'- hydroxycarbamimidoyl)-1,2,5- oxadiazol-3-yl)thio)-N-(1- (hydroxymethyl)cyclopropyl) acetamide::US10538497, Example 202

SMILES OCC1(CC1)NC(=O)CSc1nonc1\C(Nc1ccc(F)c(Br)c1)=N\O

InChI Key InChIKey=ZBRVRLJDMGHBPF-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 430012   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM430012(US10538497, Example 202 | 2-((4-(N-(3-bromo-4- flu...)
Affinity DataIC50: 20.2nMAssay Description:HIS-tagged IDO1 protein was recombinantly expressed in Escherichia coli using ZYP5052 autoinduction media supplemented with 500 uM delta aminolevulin...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/9/2020
Entry Details
Go to US Patent